Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab

OBJECTIVE: To examine associations of body mass index (BMI), subcutaneous fat area (SFA) and density (SFD), visceral fat area (VFA) and density (VFD) and total psoas area (TPA) to outcomes among patients receiving chemotherapy with or without bevacizumab for advanced or recurrent endometrial cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillen, J., Mills, K.A., Dvorak, J., Zheng, B., Thai, T., Salani, R., Cosgrove, C.M., Davidson, B., Thaker, P.H., Moore, K.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838799/
https://www.ncbi.nlm.nih.gov/pubmed/31720357
http://dx.doi.org/10.1016/j.gore.2019.100502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838799/
https://www.ncbi.nlm.nih.gov/pubmed/31720357
http://dx.doi.org/10.1016/j.gore.2019.100502

Ejemplares similares